Real-Time Assessment of Stress and Stress Response Using Digital Phenotyping: A Study Protocol

Stephan T Egger, Marius Knorr, Julio Bobes, Abraham Bernstein, Erich Seifritz, Stefan Vetter, Stephan T Egger, Marius Knorr, Julio Bobes, Abraham Bernstein, Erich Seifritz, Stefan Vetter

Abstract

Background: Stress is a complex phenomenon that may have a negative influence on health and well-being; consequently, it plays a pivotal role in mental health. Although the incidence of mental disorders has been continuously rising, development of prevention and treatment methods has been rather slow. Through the ubiquitous presence of smartphones and wearable devices, people can monitor stress parameters in everyday life. However, the reliability and validity of such monitoring are still unsatisfactory. Methods: The aim of this trial is to find a relationship between psychological stress and saliva cortisol levels on the one hand and physiological parameters measured by smartphones in combination with a commercially available wearable device on the other. Participants include cohorts of individuals with and without a psychiatric disorder. The study is conducted in two settings: one naturalistic and one a controlled laboratory environment, combining ecological momentary assessment (EMA) and digital phenotyping (DP). EMA is used for the assessment of challenging and stressful situations coincidentally happening during a whole observation week. DP is used during a controlled stress situation with the Trier Social Stress Test (TSST) as a standardized psychobiological paradigm. Initially, participants undergo a complete psychological screening and profiling using a standardized psychometric test battery. EMA uses a smartphone application, and the participants keep a diary about their daily routine, activities, well-being, sleep, and difficult and stressful situations they may encounter. DP is conducted through wearable devices able to continuously monitor physiological parameters (i.e., heart rate, heart rate variability, skin conductivity, temperature, movement and acceleration). Additionally, saliva cortisol samples are repeatedly taken. The TSST is conducted with continuous measurement of the same parameters measured during the EMA. Discussion: We aim to identify valid and reliable digital biomarkers for stress and stress reactions. Furthermore, we expect to find a way of early detection of psychological stress in order to evolve new opportunities for interventions reducing stress. That may allow us to find new ways of treating and preventing mental disorders. Trial Registration: The competing ethics committee of the Canton of Zurich, Switzerland, approved the study protocol V05.1 May 28, 2019 [BASEC: 2019-00814]; the trial was registered at ClinicalTrials.gov [NCT04100213] on September 19, 2019.

Keywords: cortisol; digital phenotyping; ecological moment assessment; stress; trier social stress test.

Copyright © 2020 Egger, Knorr, Bobes, Bernstein, Seifritz and Vetter.

Figures

Figure 1
Figure 1
Study Outline. The initial and final evaluations (green) include a psychological test battery and the collection of cortisol samples. Well-being and basal cortisol levels are assessed daily at fixed time frames (only morning and night assessment shown). During the TSST-G (blue) DP, stress and cortisol levels are conducted. Coincidentally experienced challenging of stressful situations/events (red) are assessed shortly after they occur (shown for illustrative purposes only). Physiological parameters are continuously assessed through wearable devices.
Figure 2
Figure 2
SPIRIT Study Schedule (EMA, Ecological Momentary Assessment; TSST-G, Trier Social Stress Test for Groups). The bar denotes the different parts of the intervention (compare Figure 3). ti−2/−1 briefing and tension release exercise previous to the TSST-G; ti1TSST-G Speech; ti2TSST-G Math; ti3/9TSST-G debriefing and tension release.
Figure 3
Figure 3
Outline for the Trier Social Stress Test (for Groups). Physiological parameters are continuously monitored. At each time point, a psychological stress response assessment takes place and a saliva cortisol sample is collected.

References

    1. Selye H. Stress and the general adaptation syndrome. Br Med J. (1950) 1:1383. 10.1136/bmj.1.4667.1383
    1. Mcewen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. (2007) 87:873–904. 10.1152/physrev.00041.2006
    1. Mccarty R. Learning about stress: neural, endocrine and behavioral adaptations. Stress. (2016) 19:449–75. 10.1080/10253890.2016.1192120
    1. Draghici AE, Taylor JA. The physiological basis and measurement of heart rate variability in humans. J Physiol Anthropol. (2016) 35:22. 10.1186/s40101-016-0113-7
    1. Karemaker JM. An introduction into autonomic nervous function. Physiol Meas. (2017) 38:R89–118. 10.1088/1361-6579/aa6782
    1. Engert V, Kok BE, Puhlmann LMC, Stalder T, Kirschbaum C, Apostolakou F, et al. . Exploring the multidimensional complex systems structure of the stress response and its relation to health and sleep outcomes. Brain Behav Immun. (2018) 73:390–402. 10.1016/j.bbi.2018.05.023
    1. Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA. (2007) 298:1685–7. 10.1001/jama.298.14.1685
    1. Bracha HS. Freeze, flight, fight, fright, faint: adaptationist perspectives on the acute stress response spectrum. J CNS Spect. (2004) 9:679–85. 10.1017/S1092852900001954
    1. Zannas AS, West AE. Epigenetics and the regulation of stress vulnerability and resilience. Neuroscience. (2014) 264:157–70. 10.1016/j.neuroscience.2013.12.003
    1. Wakefield JC. The concept of mental disorder. On the boundary between biological facts and social values. Am Psychol. (1992) 47:373–88. 10.1037/0003-066X.47.3.373
    1. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. . Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. (2018) 392:1789–858. 10.1016/S0140-6736(18)32279-7
    1. Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. . Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. (2018) 392:1859–922. 10.1016/S0140-6736(18)32335-3
    1. Insel TR. Digital phenotyping: a global tool for psychiatry. World Psychiatry. (2018) 17:276–7. 10.1002/wps.20550
    1. Mercer K, Giangregorio L, Schneider E, Chilana P, Li M, Grindrod K. Acceptance of commercially available wearable activity trackers among adults aged over 50 and with chronic illness: a mixed-methods evaluation. JMIR Mhealth Uhealth. (2016) 4:e7. 10.2196/mhealth.4225
    1. Dagum P. Digital biomarkers of cognitive function. npj Digital Med. (2018) 1:10. 10.1038/s41746-018-0018-4
    1. Reinertsen E, Clifford GD. A review of physiological and behavioral monitoring with digital sensors for neuropsychiatric illnesses. Physiol Meas. (2018) 39:05TR01. 10.1088/1361-6579/aabf64
    1. Smets E, Rios Velazquez E, Schiavone G, Chakroun I, D'hondt E, De Raedt W, et al. . Large-scale wearable data reveal digital phenotypes for daily-life stress detection. npj Digital Med. (2018) 1:67. 10.1038/s41746-018-0074-9
    1. Torous J, Keshavan M. A new window into psychosis: The rise digital phenotyping, smartphone assessment, and mobile monitoring. Schizophr Res. (2018) 197:67–8. 10.1016/j.schres.2018.01.005
    1. Hirschtritt ME, Insel TR. Digital technologies in psychiatry: present and future. Focus. (2018) 16:251–8. 10.1176/appi.focus.20180001
    1. Jain SH, Powers BW, Hawkins JB, Brownstein JS. The digital phenotype. Nat Biotechnol. (2015) 33:462–3. 10.1038/nbt.3223
    1. Insel TR. Digital phenotyping: technology for a new science of behavior. JAMA. (2017) 318:1215–6. 10.1001/jama.2017.11295
    1. Lesser IM. A review of the alexithymia concept. Psychosom Med. (1981) 43:531–43. 10.1097/00006842-198112000-00009
    1. Larsen JK, Brand N, Bermond B, Hijman R. Cognitive and emotional characteristics of alexithymia: a review of neurobiological studies. J Psychosom Res. (2003) 54:533–41. 10.1016/S0022-3999(02)00466-X
    1. Bakker D, Kazantzis N, Rickwood D, Rickard N. Mental health smartphone apps: review and evidence-based recommendations for future developments. JMIR Ment Health. (2016) 3:e7. 10.2196/mental.4984
    1. Roberts LW, Torous J. Preparing residents and fellows to address ethical issues in the use of mobile technologies in clinical psychiatry. Acad Psychiatry. (2017) 41:132–4. 10.1007/s40596-016-0594-z
    1. Peake JM, Kerr G, Sullivan JP. A critical review of consumer wearables, mobile applications, and equipment for providing biofeedback, monitoring stress, and sleep in physically active populations. Front Physiol. (2018) 9:743. 10.3389/fphys.2018.00743
    1. Kirschbaum C, Pirke KM, Hellhammer DH. The 'Trier Social Stress Test'–a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology. (1993) 28:76–81. 10.1159/000119004
    1. Middelkoop HA, Van Dam EM, Smilde-Van Den Doel DA, Van Dijk G. 45-hour continuous quintuple-site actimetry: relations between trunk and limb movements and effects of circadian sleep-wake rhythmicity. Psychophysiology. (1997) 34:199–203. 10.1111/j.1469-8986.1997.tb02132.x
    1. Salmaso D, Longoni AM. Problems in the assessment of hand preference. Cortex. (1985) 21:533–49. 10.1016/S0010-9452(58)80003-9
    1. Verhelst N, Van Avermaet P, Takala S, Figueras N, North B. Common European Framework of Reference for Languages: Learning, Teaching, Assessment. Strasbourg: Cambridge University Press; (2009).
    1. World Health Organization . ICD-10: International Statistical Classification of Diseases and Related Health Problems. Genève: World Health Organization; (2004).
    1. Fervaha G, Hill C, Agid O, Takeuchi H, Foussias G, Siddiqui I, et al. . Examination of the validity of the brief neurocognitive assessment (BNA) for schizophrenia. Schizophr Res. (2015) 166:304–9. 10.1016/j.schres.2015.05.015
    1. Derogatis L, Melisaratos N. The brief symptom inventory: an introductory report. Psychol Med. (1983) 3:595–605. 10.1017/S0033291700048017
    1. Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; (1976).
    1. Rush A, Jr, First MB, Blacker DE. Handbook of Psychiatric Measures. Philadelphia, PA: American Psychiatric Publishing, Inc. (2008).
    1. Jean Endicott P, Robert L, Spitzer M, Joseph L, Fleiss P, Jacob Cohen P. The global assessment scale. Arch Gen Psychiatry. (1976) 33:766–71. 10.1001/archpsyc.1976.01770060086012
    1. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. (1959) 32:50–5. 10.1111/j.2044-8341.1959.tb00467.x
    1. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. (1960) 23:56–62. 10.1136/jnnp.23.1.56
    1. Wing J, Beevor A, Curtis R, Park S, Hadden S, Burns A. Health of the Nation Outcome Scales (HoNOS). Research and development. Br J Psychiatry. (1998) 172:11–8. 10.1192/bjp.172.1.11
    1. Wing J, Curtis R, Beevor A. Health of the Nation Outcome Scales (HoNOS). Glossary for HoNOS score sheet. Br J Psychiatry. (1999) 174:432–4. 10.1192/bjp.174.5.432
    1. Albani C, Schmutzer G, Blaser G, Körner A, Nawroth C, Geyer M, et al. . Die Entwicklung einer Kurzversion (U-Bogen-24) des Unsicherheitsfragebogens von Ullrich und Ullrich de Muynck. Psychother Psychosomatik Med Psychol. (2005) 56:118–27. 10.1055/s-2005-915332
    1. Linden M, Baron S. [The “Mini-ICF-Rating for Mental Disorders (Mini-ICF-P)”. A short instrument for the assessment of disabilities in mental disorders]. Rehabilitation. (2005) 44:144–51. 10.1055/s-2004-834786
    1. Baron S, Linden M. [Analyzing the effectiveness of inpatient psychosomatic rehabilitation using the mini-ICF-APP]. Rehabilitation. (2009) 48:145–53. 10.1055/s-0029-1220740
    1. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. . The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J CLin Psychiatry. (1998) 59 (Suppl. 20):22–33. 10.1037/t18597-000
    1. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. (2005) 53:695–9. 10.1111/j.1532-5415.2005.53221.x
    1. Damian AM, Jacobson SA, Hentz JG, Belden CM, Shill HA, Sabbagh MN, et al. . The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord. (2011) 31:126–31. 10.1159/000323867
    1. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. (1987) 13:261–76. 10.1093/schbul/13.2.261
    1. Hoffmann RM, Müller T, Hajak G, Cassel W. Abend-Morgenprotokolle in Schlafforschung und Schlafmedizin—Ein Standardinstrument für den deutschsprachigen Raum. Somnologie. (1997) 1:103–9. 10.1007/s11818-997-0019-z
    1. Müller B, Basler H-D. Kurzfragebogen zur aktuellen Beanspruchung: KAB. Weinheim: Beltz; (1993).
    1. Kupfer J, Brosig B, Brähler E. Testing and validation of the 26-Item Toronto Alexithymia Scale in a representative population sample. Zeitschrift Psychosomatische Med Psychother. (2000) 46:368–84. 10.13109/zptm.2000.46.4.368
    1. Taylor GJ, Bagby RM, Parker JDA. The 20-item toronto alexithymia scale. J Psychosomatic Res. (2003) 55:277–83. 10.1016/S0022-3999(02)00601-3
    1. Kooiman CG, Spinhoven P, Trijsburg RW. The assessment of alexithymia: a critical review of the literature and a psychometric study of the Toronto Alexithymia Scale-20. J Psychosom Res. (2002) 53:1083–90. 10.1016/S0022-3999(02)00348-3
    1. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. . The Yale-Brown obsessive compulsive scale: I. Development, use, and reliability. Arch Gen Psychiatry. (1989) 46:1006–11. 10.1001/archpsyc.1989.01810110048007
    1. Young R, Biggs J, Ziegler V, Meyer D. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. (1978) 133:429–35. 10.1192/bjp.133.5.429
    1. Thiele C, Laireiter A-R, Baumann U. Diaries in clinical psychology and psychotherapy: a selective review. Clin Psychol Psychother. (2002) 9:1–37. 10.1002/cpp.302
    1. Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol. (2008) 4:1–32. 10.1146/annurev.clinpsy.3.022806.091415
    1. Barrios L, Oldrati P, Santini S, Lutterotti A. Evaluating the accuracy of heart rate sensors based on photoplethysmography for in-the-wild analysis. In: Proceedings of the 13th EAI International Conference on Pervasive Computing Technologies for Healthcare - PervasiveHealth'19. Trento: (2019).
    1. Dahlgren A, Kecklund G, Theorell T, Akerstedt T. Day-to-day variation in saliva cortisol–relation with sleep, stress and self-rated health. Biol Psychol. (2009) 82:149–55. 10.1016/j.biopsycho.2009.07.001
    1. Adam EK, Hawkley LC, Kudielka BM, Cacioppo JT. Day-to-day dynamics of experience–cortisol associations in a population-based sample of older adults. Proc Natl Acad Sci USA. (2006) 103:17058–63. 10.1073/pnas.0605053103
    1. Hellhammer J, Fries E, Schweisthal OW, Schlotz W, Stone AA, Hagemann D. Several daily measurements are necessary to reliably assess the cortisol rise after awakening: state- and trait components. Psychoneuroendocrinology. (2007) 32:80–6. 10.1016/j.psyneuen.2006.10.005
    1. Birkett MA. The trier social stress test protocol for inducing psychological stress. J Vis Exp. (2011) 56:3238. 10.3791/3238
    1. Allen AP, Kennedy PJ, Dockray S, Cryan JF, Dinan TG, Clarke G. The trier social stress test: principles and practice. Neurobiol Stress. (2017) 6:113–26. 10.1016/j.ynstr.2016.11.001
    1. Goodman WK, Janson J, Wolf JM. Meta-analytical assessment of the effects of protocol variations on cortisol responses to the Trier Social Stress Test. Psychoneuroendocrinology. (2017) 80:26–35. 10.1016/j.psyneuen.2017.02.030
    1. Vors O, Marqueste T, Mascret N. The trier social stress test and the trier social stress test for groups: qualitative investigations. PLoS ONE. (2018) 13:e0195722. 10.1371/journal.pone.0195722
    1. Hellhammer J, Schubert M. The physiological response to Trier Social Stress Test relates to subjective measures of stress during but not before or after the test. Psychoneuroendocrinology. (2012) 37:119–24. 10.1016/j.psyneuen.2011.05.012
    1. Henze GI, Zankert S, Urschler DF, Hiltl TJ, Kudielka BM, Pruessner JC, et al. . Testing the ecological validity of the Trier Social Stress Test: Association with real-life exam stress. Psychoneuroendocrinology. (2017) 75:52–5. 10.1016/j.psyneuen.2016.10.002
    1. Childs E, Vicini LM, De Wit H. Responses to the Trier Social Stress Test (TSST) in single versus grouped participants. Psychophysiology. (2006) 43:366–71. 10.1111/j.1469-8986.2006.00414.x
    1. Von Dawans B, Kirschbaum C, Heinrichs M. The trier social stress test for groups (TSST-G): a new research tool for controlled simultaneous social stress exposure in a group format. Psychoneuroendocrinology. (2011) 36:514–22. 10.1016/j.psyneuen.2010.08.004
    1. Boesch M, Sefidan S, Ehlert U, Annen H, Wyss T, Steptoe A, et al. . Mood and autonomic responses to repeated exposure to the Trier Social Stress Test for Groups (TSST-G). Psychoneuroendocrinology. (2014) 43:41–51. 10.1016/j.psyneuen.2014.02.003
    1. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. (2007) 39:175–91. 10.3758/BF03193146
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York, NY: Academic Press; (1969).
    1. Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. (2019) 380:1347–58. 10.1056/NEJMra1814259
    1. Cheng SC, Walsh E, Schepp KG. Vulnerability, stress, and support in the disease trajectory from prodrome to diagnosed schizophrenia: diathesis-stress-support model. Arch Psychiatr Nurs. (2016) 30:810–7. 10.1016/j.apnu.2016.07.008
    1. Caspi A, Moffitt TE. All for one and one for all: mental disorders in one dimension. Am J Psychiatry. (2018) 175:831–44. 10.1176/appi.ajp.2018.17121383
    1. Mercer K, Li M, Giangregorio L, Burns C, Grindrod K. Behavior change techniques present in wearable activity trackers: a critical analysis. JMIR Mhealth Uhealth. (2016) 4:e40. 10.2196/mhealth.4461
    1. Tsesis A. The right to erasure: privacy, data brokers, and the indefinite retention of data. Wake For Lake Rev. (2014) 49:433.
    1. Commission USFT . Lumosity to Pay $2 Million to Settle FTC Deceptive Advertising Charges for Its “Brain Training” Program. (2016). Available online at: (accessed January 1, 2019).
    1. Huckvale K, Prieto JT, Tilney M, Benghozi P-J, Car J. Unaddressed privacy risks in accredited health and wellness apps: a cross-sectional systematic assessment. BMC Med. (2015) 13:214. 10.1186/s12916-015-0444-y
    1. Torous JB, Chan SR, Gipson SYT, Kim JW, Nguyen TQ, Luo J, et al. . A hierarchical framework for evaluation and informed decision making regarding smartphone apps for clinical care. Psychiatr Serv. (2018) 69:498–500. 10.1176/appi.ps.201700423
    1. Veale M, Binns R, Edwards L. Algorithms that remember: model inversion attacks and data protection law. Philos Transact Ser A Math Phys Eng Sci. (2018) 376:20180083. 10.1098/rsta.2018.0083
    1. Torous J, Haim A. Dichotomies in the development and implementation of digital mental health tools. Psychiatr Serv. (2018) 69:1204–6. 10.1176/appi.ps.201800193
    1. Anthes E. Mental health: there's an app for that. Nat News. (2016) 532:20. 10.1038/532020a
    1. Plana-Ripoll O, Pedersen CB, Holtz Y, Benros ME, Dalsgaard S, De Jonge P, et al. . Exploring comorbidity within mental disorders among a danish national population. JAMA Psychiatry. (2019) 76:259–70. 10.1001/jamapsychiatry.2018.3658
    1. Bonney R, Shirk JL, Phillips TB, Wiggins A, Ballard HL, Miller-Rushing AJ, et al. . Next steps for citizen science. Science. (2014) 343:1436–7. 10.1126/science.1251554

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera